Table 2.
ST3GAL6 as a prognostic variable in MM
| HR | HR 95% confidence interval | P value | |
|---|---|---|---|
| High ST3GAL6 | 1.47 | 1.01-2.13 | .04 |
| ISS stage | 1.5 | 1.20-1.87 | <.001 |
| Adverse IgH | 1.5 | 1.0-2.37 | .05 |
| Gain 1q | 1.5 | 1.05-2.28 | .03 |
ST3GAL6 as a prognostic variable in MM
| HR | HR 95% confidence interval | P value | |
|---|---|---|---|
| High ST3GAL6 | 1.47 | 1.01-2.13 | .04 |
| ISS stage | 1.5 | 1.20-1.87 | <.001 |
| Adverse IgH | 1.5 | 1.0-2.37 | .05 |
| Gain 1q | 1.5 | 1.05-2.28 | .03 |